BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30324876)

  • 21. USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer.
    Wang S; Zhong X; Wang C; Luo H; Lin L; Sun H; Sun G; Zeng K; Zou R; Liu W; Sun N; Song H; Liu W; Zhang Q; Liao Z; Teng X; Zhou T; Sun X; Zhao Y
    Cell Death Differ; 2020 Nov; 27(11):3131-3145. PubMed ID: 32494025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
    Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of estrogen receptor-α upregulation in breast cancers.
    Miyoshi Y; Murase K; Saito M; Imamura M; Oh K
    Med Mol Morphol; 2010 Dec; 43(4):193-6. PubMed ID: 21267694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
    Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
    J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
    Fan M; Bigsby RM; Nephew KP
    Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
    Stender JD; Nwachukwu JC; Kastrati I; Kim Y; Strid T; Yakir M; Srinivasan S; Nowak J; Izard T; Rangarajan ES; Carlson KE; Katzenellenbogen JA; Yao XQ; Grant BJ; Leong HS; Lin CY; Frasor J; Nettles KW; Glass CK
    Mol Cell; 2017 Mar; 65(6):1122-1135.e5. PubMed ID: 28306507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer.
    Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance.
    Jehanno C; Fernandez-Calero T; Habauzit D; Avner S; Percevault F; Jullion E; Le Goff P; Coissieux MM; Muenst S; Marin M; Michel D; Métivier R; Flouriot G
    Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194507. PubMed ID: 32113984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α monoubiquitination.
    La Rosa P; Pesiri V; Marino M; Acconcia F
    Cell Signal; 2011 Jul; 23(7):1128-35. PubMed ID: 21356307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 37. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
    Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
    Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
    Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
    EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.
    Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.